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ABSTRACT 
Graphene oxide (GO) is a versatile, monomolecular layered nanomaterial that possess various 
oxygen containing functionality on its large surface.  These characteristics allow GO to interact 
with a variety of materials, for application to a number of areas.  The strength and selectivity of 
these interactions can be improved significantly through further functionalization.  In this paper 
we describe the functionalization of GO and its application as a protein ligand and an enzyme 
inhibitor. The work reported in this paper details how chymotrypsin inhibition can be improved 
using GO functionalized with a monomeric and oligomer layer of tyrosine.  The results indicated 
that the mono and oligo functionalized systems performed extremely well, with Ki values nearly 
four times better than GO alone.  Our original premise was that the oligomeric system would bind 
better, due to the length of the oligomeric arms and potential for a high degree of flexibility.  
However, the results clearly showed that the shorter monomeric system was the better 
ligand/inhibitor.   This was due to weaker intramolecular interactions between the aromatic side 
chains of tyrosine and the aromatic surface of GO.  Although these are possible for both systems, 
they are cooperative and therefore stronger, for the oligomeric functionalized GO.  As such, the 
protein must compete and overcome these cooperative intramolecular interactions before it can 
bind to the functionalized GO.  Whereas, the tyrosines on the surface of the monomeric system 
interact with the surface of GO through a significantly weaker mono-valent interaction, but interact 
cooperatively with the protein surface.  
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INTRODUCTION 
Graphene oxide (GO) and functionalized GO are important materials that can interact with other 
materials and be applied to a number of important areas.  One such are is protein binding and 
enzyme inhibition.  Most proteins function through cooperative partnerships with other proteins.1 
The complexes formed play essential roles in all biological processes and any unwanted or 
uncontrolled interactions can result in disease.2  Modulating these interactions is central to drug 
design. Proteins recognize each other and other molecules through complementary functionalities 
positioned at precise points on large interacting surfaces, the key component of which is known as 
the “hot spot” or interfacial area. 1,3 These surfaces involve specific interactions and range in size 
from 500┭2 to 5000┭2. Due to the size of these surfaces,4,5 it makes sense to design inhibitors and 
ligands that are large enough to interact fully with large interfacial binding areas.    As such, there 
have been a number of approaches to study protein-ligand binding and/or inhibit protein-protein 
interactions using various macromolecules.  These include calixarene and porphyrin scaffolds,6,7 
nanomaterials,8 linear polymers,9-10 and dendrimers.11-12 Graphene oxide has been shown to be an 
excellent material for protein binding.13 as it has a number of oxygen containing functional groups 
on its surface, including carboxylic acids.   Weight for weight, GO is currently the best 
ligand/inhibitor of the protein/enzyme chymotrypsin.13 In common with the macromolecules 
described above, GO possess carboxylic acids that can interact with protein binding surfaces rich 
in cationic functionality.   However, as well as size and simple electrostatics, a number of other 
non-covalent interactions are also important and these have a significant role with respect to 
selectivity (including charge/charge, hydrophobic, aromatic/ヾ−ヾ interactions and hydrogen 
bonding).   In Nature, these specific interactions come from a relatively narrow range of key amino 
acids.  Studies have identified amino acids that contributed on average, more than 2 kcal/mol to 
the binding energy and only three amino acids were found to appear in interfacial areas with a 
frequency of more than 10%.14  These were amino acids capable of making multiple interactions 
and include; tryptophan 21%, arginine 14% and tyrosine 13%. As such, multi/polyvalency, 
functionality, charge and size are key design determinants with respect to obtaining selective 
ligands for protein binding.  Therefore, changes in binding strength occurs when functionalized 
macromolecules are used as protein ligands.  These include functionalized porphyrins,15 linear 
polymers 16 and dendrimers.17   
The aim of the work described within this paper was determine whether or not the already 
significant protein binding ability of GO could be improved through functionalization. Of 
Particular interest, is functionalization with amino acids.  One possible and simple way of 
achieving this is through the use of non-covalent chemistry.  It is known that charged and aromatic 
amino acids can form relatively strong interactions with GO. 18 However, in the presence of a 
protein, competition for amino acid binding, between the GO and the protein, results in a decreased 
interaction (due to a reduction in the number of multivalent interactions).  Furthermore, previous 
studies to quantify binding (between GO and the amino acids) have reported that binding is 
relatively weak and only takes place at mM concentrations. 19  As well as providing a level of 
robustness for any future applications, a covalent approach would allow much lower 
concentrations to be used.  With regards to covalent approaches, there have been a number of 
reports describing the functionalization of GO with amino acids, including a recent paper 
describing a Magnetic nano-hybrid system for protein purification.20 The most common method 
of functionalization describes the use of a coupling agent and an excess of amino acid in its non-
protected form.20-23   These methodologies produces a GO surface functionalized with an 
oligomeric amino acid surface.  The process involves formation of an initial monomeric 
functionalized surface that goes on to react further with the excess amino acids.  Alternatively, the 
unprotected amino acid reacts in solution t  form dimers, trimers and oligomers, which in turn add 
to the unfunctionalised or functionalized GO surface (where they are free to react further).  
Therefore, this methodology generates a functionalized GO surface with a random oligomeric 
layer of amino acids.  In addition, as the aromatic amino acids important with respect to 
protein/enzyme binding tend to be aromatic,24  the oligomeric chains will simply lay down and 
interact with the GO surface through favorable cooperative - interactions.  As a result, these 
interactions must be broken and overcome before GO can bind to a protein surface.  Additionally, 
the randomness and entropic freedom of the oligomeric chains could also lead to a lack of 
selectivity. Nevertheless, this simple method of functionalization may offer an advantage with 
respect to flexibility, resulting in high affinity and strong binding.  In contrast, a monomeric layer 
of aromatic amino acids will only bind to the surface of GO through a single  interaction.  
Therefore, these monomeric interactions will be significantly weaker than the oligomer’s 
cooperative interactions (with the GO surface).  Consequently, it will be much easier for the 
monomeric amino acid system to interact with a protein surface. On the other hand, as the distance 
between the GO surface and the target protein could be much shorter for the monomeric system, 
there may be steric issues that could weaken binding.  In addition, the lack of flexibility for the 
monomeric system could result in a improved selectivity.25  It is also possible that neither will bind 
particularly well, and that unfunctionalised GO is in fact the best ligand. Therefore, each system 
has advantages and disadvantages and an argument can be made for either with respect to protein 
binding.  Without experimentation, it is not obvious which GO system will bind best to a target 
protein. To test this proposition, we proposed to functionalize the surface of GO with a monomeric 
and an oligomeric layer of tyrosine and to assess their binding affinities. Binding of the mono and 
oligo layered systems will be assessed relative to their ability to inhibit the activity of the protein 
-chymotrypsin.  Control experiments using unfunctionalised GO will also be carried out.  
Assessment of binding through inhibition experiments is possible, because the substrate entrance 
to the active site of -chymotrypsin sits in the middle of its binding/interfacial area. Therefore, 
when GO binds, it blocks the active site entrance and the substrate cannot enter.12 This will result 
in a reduction of the enzyme’s activity, which can be used to assess relative binding efficiency.16 
Kinetic data obtained using various substrate and GO concentrations will be used to determine 
kinetic parameters, including Km, kcat , Vmax and  values, as well as determining the mode of 
binding.   
 
 
RESULTS AND DISCUSSION 
Synthesis of oligomeric and monomeric tyrosine functionalized graphene oxide 
Our aims were two fold.  Firstly, to test whether or not a functionalized GO would bind to protein 
surfaces with a higher affinity than GO alone.  Secondly, we also wanted to determine whetherthe 
oligomeric or monomeric system bound with the greater affinity. To test our aims and 
methodology, we decided to functionalize GO with monomeric and oligomeric tyrosine.  This 
amino acid possess hydrophobic,  and H-bonding interactions and contributes more than 2 
kcal/mol to the binding energy.14  Furthermore, tyrosine appears at the surface of proteins with a 
frequency of 13%, despite having a low overall frequency throughout protein structures.  Tyrosine 
is therefore considered an important amino acid with respect to strong protein-protein binding.14     
 
 Scheme 1; Synthesis of oligomeric tyrosine and possible binding on the surface of GO. 
   
 
The graphene oxide required for our studies was synthesized using a variation of the Hummers 
method.23 The structure of the GO obtained was confirmed by comparing its characterization data 
with published data (data provided in the supporting information).23,26-28   The next step was 
functionalization with a monomeric and oligomeric layer of amino acid. The oligomeric system 
was synthesized simply by adding EDC and non-protected tyrosine to a suspension of GO in water 
and stirring for 24 hours at 70 °C.  The process is shown schematically in Scheme 1.  The 
monomeric system was synthesized using the same initial step, except that the methoxy ester of 
tyrosine was used.  After isolation, the functionalized GO was resuspended in water and the ester 
group hydrolyzed using sodium hydroxide.  A schematic representation of the two-step procedure 
is shown in Scheme 2.   
  
 
Scheme 2; Synthesis of a monomeric layer of tyrosine on the surface of GO, in its protected and 
deprotected forms.  
 
For the oligomeric system, peaks at 1582-1700 cm-1, corresponding to the C=O of amide and 
carboxylate groups, were visible in the FTIR spectrum. The NH stretching peak was observed at 
3458 cm-1.  For the ester protected system, the C=O peak started around 1600 cm-1, but extended 
to 1750 cm-1, as a consequence of to the ester carbonyl stretch. In addition, no peaks corresponding 
to a carboxylic acid’s OH stretch were visible (around 3000-3500 cm-1).   However, after 
deprotection, the OH peak returns to the spectrum, and the carbonyl peak no longer extends to th  
ester region (1750 cm-1), confirming hydrolysis of the ester protecting group.  Elemental analysis 
provided further support for functionalization and could also provide some information regarding 
the extent of functionalization.   The carbon content increased from 40% for GO, to 45 and 48% 
for the monomeric and oligomeric systems respectively.  This increase in carbon content with an 
increasing level of functionalization is consistent with other reports.21  Elemental analysis also 
showed that nitrogen was present in both the monomeric and oligomeric systems, with a higher 
percentage observed for the oligomeric system (5.5 % and 3% for the oligo and monomeric 
systems respectively).   On its own, this does not necessarily indicate a higher level of 
functionalization, as this is dependent on the relative amounts of the other elements present.  
However, the carbon to nitrogen ratio can be used to assess qualitatively the relative levels of 
functionalization.   A lower ratio indicates a higher proportion of nitrogen relative to the carbon 
content. The ratio for the two systems was 1:8 and 1:16 for the oligomeric and monomeric species 
respectively, confirming a higher level of functionalization for the oligomeric system.  SEM-EDX 
mapping of the GO surface showed that only carbon and oxygen were present, whilst images for 
the monomeric and oligomeric samples also showed nitrogen (see supporting information).    
Furthermore, quantitative SEM-EDX analysis indicated a carbon to nitrogen ratio of 1:4 for the
oligomer and 1:10 for the monomer, which correlate reasonably well with elemental analysis.  
TGA analysis of GO was identical to published data, with decomposition taking place in three 
phases. Initially, around 25% weight loss occurred at 50–12 °C, which was related to the loss of 
water. The second phase occurring between 120-440°C, corresponded to the loss of oxygen-
containing groups and accounted for around 30% weight loss. The final phase took place between 
440 °C and 750 °C (when the measurement was stopped) and is due to the pyrolysis of oxygen and 
unstable carbons remaining in the structure to yield CO and CO2.25-27 The monomeric and 
oligomeric systems decomposed differently, with both showing the same initial degradation 
corresponding to loss of water.  This was followed by a second decomposition from 100-600 °C 
(accounting for around 50% loss of weight) for the monomer.  The oligomeric system was equally 
unstable, showing a continuous decomposition from 120 °C to 450°C, which accounted for nearly 
80% of the lost weight.  For both systems, this was followed by a final pyrolysis stage from 600 °C 
to 750 °C.  The different degradation behavior of the functionalized systems (with respect to GO) 
is a result of the amino acid and oligomer degradation,  
 
Figure 1 RAMAN spectra of GO and the oligomeric and monomeric tyrosine systems. 
 
RAMAN spectroscopy was used to identify the bond type/hybridization of the material, Figure 1.  
The RAMAN spectra of graphite has a single peak at 1575 cm-1 and this is associated with the sp2
carbon bonds, Figure 1.  As well as the sp2 peak at 1593cm-1, GO also has as second peak at 1355 
cm−1, which is attributed to sp3 atoms.  These two peaks are often referred to as the G and D-bands 
respectively and the ratio of these two bands is an indicator of the level of functionalization.  The 
ID/IG ratio for our GO was 0.80, which indicates a relatively high level of oxidation and generation 
of sp3 atoms via the attachment of oxygen-containing functional groups.27-29 GO also has a broad 
peak at 2500–3200 cm−1, which is referred to as the 2D band.   The I2D/IG ratio can be used to 
estimate the number of GO layers.30  In our case it was estimated that GO sheets with less than 
five layers had formed.31 Functionalization of GO with tyrosine shifted the G and D bands to 1591 
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and 1352 cm−1 respectively. The ID/IG ratios for the monomeric systems increased to 0.86, which 
indicates an increased level of sp3 atoms and further supports successful functionalization.  F r the 
oligomeric system, the ID/IG ratio increased further to 1.02, confirming an even greater extent of 
functionalization. XRD analysis of the functionalized systems showed that the original peak at 
10°for GO, had shifted to 8.78°. The spectra also had a broad peak around 26°, which is consistent 
with an aromatic surface.32-33 The distance at the 2し position was used to calculate the interlayer 
distance or d spacing.  For the monomeric system this was measured as 0.86 nm, which is slightly 
higher than the 0.80 nm recorded for GO.  This similarity is to be expected, as tyrosine is small 
and the aromatic functional groups are probably lying flat on the surface and minimizing the d 
spacing (as a result of  interactions).  However, the d spacing for the oligomeric system was 
larger at 1.00 nm, which is greater than either the GO, or the monomeric functionalized system.  
Again, this to be expected as the oligomeric system is longer/bigger and will take up more space 
on the surface.  Although the aromatic rings can lay flat on the surface, it is not necessarily true 
that all of the aromatic rings will, or can lay flat.  This is particularly true for longer oligomers, 
where it is likely that “kinks” or “bulges” may form on the surface, which accounts for the higher 
d spacing. 
 
XPS was used to probe the electronic/bonding environment of various atoms.  The N 1s XPS 
spectra showed two peaks, indicating two main bonding states of nitrogen (see supporting 
information).  The first, at a binding energy of 400.35 eV, is attributed to the nitrogen in the amide 
bond, which form when the amino acid reacts with the carboxylates on the surface (or the growing 
oligomer).  The second peak comes at 400.7 eV and can be assigned to a nitrogen in an amine 
bond.23,34 The ratio of amide and amine peaks was 1 to 0.33 and 1 to 1.35, for the oligomer and 
monomer respectively.  This indicates that more amine bonds have formed in the monomeric 
system and this disparity comes from the differences in synthetic methods.  During the synthesis 
the N-terminus of the amino acid can react with the surface carboxylate groups to generate amides.  
However, the N-terminus can also react with the epoxides on the surface of GO, to give an amine 
and this is possible for both the oligomeric and monomeric synthesis.  However, as a non-protected 
tyrosine is used in the oligomeric method, the N-terminus can also react with the C-terminus of 
another amino acid or a growing oligomer.  Either will result in the formation of additional amide 
bonds resulting in fewer amines and this is the reason why the amide peak for the oligomeric 
system is much higher/more intense than the monomeric system.  Overall, this supports our earlier 
assumption that oligomers form when non-protected amino acids are used.  Having synthesized 
and characterized the functionalized GO systems, we were now in a position to test their protein 
binding abilities. 
 
Assessment of protein binding using an enzyme inhibition assay 
Protein binding of the functionalized GO was assessed using an enzyme inhibition assay.  The 
basic premise is based on the assumption that binding to the surface of an enzyme may prevent or 
reduce substrate access to the active site.  This is particularly relevant for -chymotrypsin whose 
active site entrance is rich in positive charge.35 We have previously exploited this principle when 
demonstrating a size based relationship between dendrimers and protein binding.17,36 De and 
Dravid used the same premise to demonstrate how unfunctionalised GO, which is rich in negative 
charge, could interact electrostatically with -chymotrypsin.13  However, electrostatics are not the 
only interactions involved in protein binding.  The active site entrance of -chymotrypsin also 
contains functionality capable of engaging in a number of other interactions (e.g. H-bonding, , 
and hydrophobic interactions).37 Therefore, addition of complimentary functionality to the surface 
of GO should result in improved selectivity.  To test this, we carried out the hydrolysis of the 
enzyme substrate N-benzoyl tyrosine p-nitroanilide (BTNA), using -chymotrypsin.  
 
 
Scheme 3; Enzyme mediated reaction used to assess relative binding to a-chymotrypsin. 
 
Upon hydrolysis BTNA generates anaromatic species 3 that is yellow in color and can be used to 
follow the hydrolysis over time, Scheme 3.  Initial rates can then be determined from plots of 
concentration versus time for the nitro aniline product 3. Initially, a baseline/control was 
established for the activity of -chymotrypsin in the absence of inhibitor, using BTNA as the 
substrate.  The reactions were carried out using 2.0 M BTNA and 0.4 M -chymotrypsin. The 
effect on the background rate for GO, the GO-Ty (mono) and GO-Ty (oligo), were determined by 
repeating the control experiment using -chymotrypsin pre-incubated with 0.24 g/mL of the 
specific inhibitor. For all experiments, the concentration of the hydrolysis product 3 was plotted 
against time, Figure 2.   Initial velocities were obtained using Graphpad 38 and fitting the data using 
linear regression.  Examination of the results (shown in Table 1) clearly indicate that all GO 
samples are effective inhibitors.  With respect to the control, the unfunctionalised GO inhibited -
chymotrypsin by around 30%.   The functionalized GOs were even better inhibitors, with the 
monomeric system being the best.  Specifically, at the concentrations used, the GO-Ty (mono) 
could inhibit more than 60% of the enzyme’s activity relative to the control (uninhibited reaction).   
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Figure 2: Rate plots used to determine the initial velocities (V) for the hydrolysis of the substrate BTNA (2.0 µM), 
using chymotrypsin (0.4 µM) in the presence and absence of GO inhibitors (0.24 µg/mL). 
 
 
 
Table 1: Initial rates determined using BTNA (2.0 M), chymotrypsin (0.4 M) and inhibitor (0.24 g/mL) 
Inhibitor No inhibitor GO GO-Tyr (oligo) GO-Tyr (mono) 
Initial rate 
(nMs-1) 
1.38 (±0.06) 0.95 (±0.04) 0.77 (±0.04) 0.51 (±0.04) 
 
To obtain more detailed inhibition and kinetic data, as well as establishing the mode of inhibition, 
initial rates for all species were determined at various inhibitor and substrate concentrations.  The 
initial rates for various inhibitor and substrate concentrations are shown in Table 2.  The initial 
rates obtained were then used to obtain Lineweaver-Burk plots and the result for the GO-Ty (mono) 
is shown in Figure 3 (top).  The plots for all inhibitor concentrations share a common intercept, 
indicating that the mode of inhibition was a competitive inhibition (Lineweaver-Burk plots for the 
other systems are included within the supporting information).   The initial rate data was 
subsequently plotted against the inverse of substrate concentration and the plots for each 
experiment fitted to an competitive inhibition model using equation 1 and Graphpad.38  Km is the 
Michaelis-Menton constant, Vmax is the maximum enzyme velocity when saturated with substrate 
and Ki is the inhibition constant. S and I are the substrate and inhibitor concentrations 
respectively.39 Plots for the GO-Ty (mono) are shown in in the bottom plot of Figure 3 (plots for 
the other systems are included within the supporting information). 
撃 噺 Vmax岷S峅 K陳 磐1+ 岷I峅Ki卑 + 岷S峅 
                                                                                                                           Equation 1 
In all cases the fit was excellent, returning R2 values greater than 0.99, confirming that the mode 
of inhibition was a competitive process.  The plots generated values for Km and Vmax values were 
similar in all cases and are shown in Table 3, along with the Ki values.  The Ki value is a measure 
of the concertation required to inhibit the activity by 50%.  Our data clearly indicates that the 
functionalized GO systems are better inhibitors than GO alone.  As inhibition is related to binding, 
we can also conclude that the functionalized GO systems bind to the protein surface more strongly 
than unfunctionalized GO, resulting in enhanced inhibition.  The strongest inhibitor was the GO-
Ty (mono), which had a Ki of 0.11 g/mL.  This was more that 200% better than the oligomeric 
system and nearly 400% better that GO alone.  Overall the data confirms that that a GO surface 
functionalized with a monomeric layer of tyrosine binds and inhibits the activity of chymotrypsin 
the best. 
 
 
 
 
Table 2: Initial rates determined using various concentrations of substrate and 
inhibitor.  All experiments conducted using 0.4 µM chymotrypsin. 
 
 
BTNA concertation 
(µM) 
 
2.0 4.0 6.0 8.0 
Control 
(0.0  µg/mL GO) 
1.38 
(±0.06) 
2.23 
(±0.09) 
2.78 
(±0.01) 
3.24 
(±0.02) 
GO 
0.06 µg/mL 
1.20 
(±0.50) 
2.10 
(±0.83) 
2.58 
(±0.90) 
3.87 
(±0.12) 
 GO 
0.12 µg/mL 
1.06 
(±0.44) 
1.89 
(±0.77) 
2.38 
(±0.96) 
2.70 
(±0.11) 
 GO 
0.24 µg/mL 
0.95 
(±0.04) 
1.69 
(±0.68) 
2.10 
(±0.86) 
2.41 
(±0.10) 
 GO 
0.48 µg/mL 
0.77 
(±0.03) 
1.40 
(±0.65) 
1.80 
(±0.78) 
2.12 
(±0.80) 
GO-Ty (oligo) 
0.06  µg/mL 
1.15 
(±0.48) 
1.94 
(±0.76) 
2.32 
(±0.97) 
2.76 
(±0.11) 
GO-Ty (oligo) 
0.12  µg/mL 
0.88 
(±0.04) 
1.74 
(±0.68) 
2.21 
(±0.93) 
2.42 
(±0.11) 
GO-Ty (oligo) 
0.24 µg/mL 
0.77 
(±0.04) 
1.48 
(±0.62) 
1.87 
(±0.75) 
2.17 
(±0.10) 
GO-Ty (oligo) 
0.48 µg/mL 
0.62 
(±0.01) 
1.12 
(±0.50) 
1.41 
(±0.65) 
1.73 
(±0.42) 
GO-Ty (mono) 
0.06  µg/mL 
1.07 
(±0.48) 
1.74 
(±0.78) 
2.16 
(±0.97) 
2.65 
(±0.12) 
GO-Ty (mono) 
0.12  µg/mL 
0.76 
(±0.42) 
1.44 
(±0.70) 
1.82 
(±0.89) 
2.11 
(±0.11) 
GO-Ty (mono) 
0.24  µg/mL 
0.51 
(±0.039) 
0.96 
(±0.06) 
1.27 
(±0.81) 
1.56 
(±0.94) 
GO-Ty (mono) 
0.48  µg/mL 
0.37 
(±0.03) 
0.71 
(±0.05) 
0.97 
(±0.07) 
1.17 
(±0.25) 
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Figure 3: Top - Lineweaver-Burk plots that show a common intercept for all concentrations of GO-Tyr (mono) 
inhibitor, which indicate a competitive inhibition mechanism. Bottom - Plots of initial rate (Table 2) vs 
concentration of substrate (BTNA) at various concentrations of GO-Tyr (mono).  The plots were fitted to a 
competitive inhibition model (equation 1 above and Graphpad), which produced values for the Ki, Km, and Vmax .  
All experiments used a fixed concentration of chymotrypsin (0.4 µM).
 
Table 3: Summary of kinetic parameters obtained for all graphene oxide inhibitors.  Data obtained from 
initial velocity vs substrate concentration and subsequent fits to a competitive inhibition model (Graphpad). 
. 
 
 
Inhibitor Km Vmax Ki g/mL 
GO 5.61 (±0.41) 5.31 (±0.19) 0.40 (±0.03) 
GO-Tyr Oligo 5.61 (±0.58) 5.28 (±0.27) 0.24 (±0.02) 
GO-Tyr Mono 5.78 (±0.53) 5.50 (±0.25) 0.11 (±0.02) 
 Having established that GO functionalized with monomeric or oligomeric layers of 
tyrosine could outperform GO as an enzyme inhibitor, we next needed to confirm that inhibition 
occurred through our proposed binding mechanism and that inhibition was not due to denaturation 
or any changes in protein structure (caused by GO binding).  This was achieved using similar 
methods to those previously used to study the effect of macro-ligand binding to the surface of 
proteins.40,41 Specifically, CD spectroscopy was used to record spectra of chymotrypsin in the 
presence and absence of the functionalized GO systems.  The spectra were then compared to each 
other to determine whether or not binding to the protein’s surface resulted in changes to the 
secondary structure.  Experiments were carried out after a 1-hour incubation and concentrations of 
0.4 たM and 0.48 たg/mL for the protein and GO systems respectively. All measurements were 
carried out at 37°C and at pH 7.35.  The spectra obtained, which are shown in Figure 4, clearly 
show that none of the GO systems have any effect on the spectra, and therefore no effect on the 
structure of the protein.  The experiments were repeated after 24 and 36 hours, and no changes in 
the spectra were observed.  Therefore, the GO systems inhibit enzymatic activity without 
denaturing the protein. This means that the GO sheets are able to adapt their structure sufficiently 
to match the surface curvature of the protein.42 As well as monitoring the structures over time, we 
also studied the effect of heat on the structure of Chy in the presence and absence of the GO.40, 41 
Experiments were performed at the same concentrations and pH (described above).  The samples 
were heated up and the intensity of the peak at 224 nm monitored with respect to temperature.  The 
results indicated no differences in the extent of denaturation with respect to temperature, 
generating identical plots for all GO systems. Therefore, binding of the GO systems did not 
destabilize or stabilize the protein structures.  This result is similar to that obtained using 
functionalized and unfunctionalised dendrimers.11 
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Figure 4: CD spectra for chymotrypsin and complexes of chymotrypsin with GO, GO-Tyr (mono) and GO-
Tyr (oligo). 
 
 
CONCLUSIONS 
Although it was known that graphene oxide could bind strongly to the surface of proteins, w  
wanted to determine if afunctionalized GO could bind proteins more strongly than a corresponding 
unfunctionalised GO. In addition to improving binding, it may also be possible (in the future) to 
introduce selectivity via functionalization.  The functionality selected for our initial study, was the 
amino acid tyrosine.  Tyrosine is one of the few amino acids known to be important with respect 
to protein-protein binding and protein-surface binding. As well as determining how a specific 
functional group may influence binding, we also wanted to know if  the extent and specific levels 
of functionalization (in regards of surface thickness and any spacer effect provided by the oligomer) 
was an important parameter with respect to protein binding.  As such, we successfully synthesized 
graphene oxide with an oligomeric layer of tyrosine using non-pr tected tyrosine and an EDC 
coupling methodology.    A monomeric functionalized graphene oxide was also synthesized using 
a simple two-step procedure.  The first of which involved the same EDC mediated addition of C-
protected tyrosine, with a second step required to hydrolyze and remove the protecting groups. All 
of the GO systems were able to inhibit the function of chymotrypsin.  Kinetic analysis indicated 
that the monomeric system inhibited the best and therefore bound the strongest, with a Ki value of 
0.11 g/mL.  This is almost four times better than GO alone (Ki 0.40 g/mL) and double the 
affinity of the oligomeric functionalized GO (Ki 0.24 g/mL).  In addition, the kinetic analysis 
confirmed all systems bound and inhibited chymotrypsin via the same competitive binding 
mechanism.  As such, any differences in binding affinity/inhibition are not related to differences 
in the mode or mechanism of binding. When analyzing the reasons for the differences in binding 
affinity, we conclude that the oligomeric system binds and inhibits less well (than the monomeric 
functionalized GO), due to unfavorable cooperative interactions between the aromatic units of the 
oligomeric chain and the graphene oxide surface.  Consequently, protein binding is in competition 
with this strong intramolecular binding, which must be overcome before the amino acids can bind 
to the protein surface.  Although the same intramolecular interactions occur for the monomeric 
system, they are unimolecular and not cooperative.  As a result, the intramolecular interaction 
between the amino acids and GO are much weaker and can be easily broken by the protein when 
binding to the amino acids through stronger intermolecular cooperative interactions.  Therefore, 
when designing GO based systems for selective protein or polyvalent binding (or any application 
requiring strong and/or selective binding to GO), it is important to take into account any 
intramolecular cooperative effects involving the GO surface, as these will weaken any 
intermolecular interactions.  Overall, we have demonstrated that functionalized GO can bind to 
chymotrypsin with high affinity and this affinity can be moderated by the level of oligomerization.  
In an effort to obtain new protein ligands and enzyme inhibitors that are more selective with respect 
to their binding, we are currently exploiting the methodology and results to design and construct 
new GO inhibitors.    
  
METHODS AND MATERIALS 
Instrumentation 
RAMAN spectrometer. Samples were recorded from 500 to 3500 cm-1 on a Renishaw 
inVianRaman Microscope using a green laser operating at wavelength of 514.5 nm and laser power 
at 20 mV.   X-ray photoelectron spectrometer (XPS) measurements were performed using 
monochromatic Al-kg radiation (hち = 1486.6λ eV). CasaXPS v 2.3.16 software was used to 
perform curve fitting and to calculate the atomic concentrations. Thermogravimetric analysis 
(TGA) were performed using a Perkin Elmer Pyris in the   range of 25°C - 800°C.  Origin 2018 
software was using to analyse the data. X-ray diffractometer (XRD) patterns were collected using 
a Bruker, D8 Advanced diffractometer with a copper target at the wave length of そ CuKg = 1.54178 
Å and a tube voltage of 40 kV and tube current of 35 mA, in the range of 5–100° at the speed of 
0.05°/min.  Elemental Analysis (EA) performed using a Vario MICRO Cube and solid powder 
was used. Scanning Electron Microscope (SEM) samples were analysed by a JEOL-7001F 
operated at 15 kV. Dry powder was used for the SEM and EDX analysis.  CD spectra were 
recorded on a Jasco spectropolarimeter model J-810, equipped with Peltier temperature-controller. 
A Quartz cell of 1cm path-length was used. Spectra were measured at 50 nm/min, 0.5 nm of data 
pitch, 1s of response, and a band width of 1 nm. The CD spectrum was recorded in millidegrees 
of ellipticity as a function of wavelength. Spectral resolution between two consecutive ellipticity 
readings is 0.5 nm. Solutions were carried out at pH 7.35 and concentrations of 0.4 たM and 0.48 
たg/mL for the protein and GO systems respectively. CD spectrum were obtained at 37°C. The 
effects of temperature on protein structure were determined by recording spectra at 1°C intervals
from 37 to 95 °C (spectra recorded at 224 nm). 
 
Synthesis  
Graphene Oxide (GO) 
Graphite flakes (3.0 g, 1.0 eq) were mixed to a 9:1 mixture of concentrated H3PO4/ H2SO4 (40: 
360 mL) and added to 18.0 g of KMnO4 (6.0 eq), a slight exotherm (around 40 °C) was produced. 
The reaction was stirred at 50 °C for 24 hours. The reaction was allowed to cool at room 
temperature and the mixture poured onto ice (500 mL), before adding 3 mL of 30% H2O2. The 
crude product was centrifuged (4000 rpm, 30 min) and the supernatant decanted away. The crude 
product was then washed several times with of water (400 mL), 30% HCl (400 mL), and ethanol 
(400 mL). Ether (400 mL) was then added to aid coagulation and the suspension collected by 
filtered. The solids were vacuum-dried for 24 hours at room temperature. The product (4.1 g) was 
obtained as a dark brown solid. 
Graphene Oxide - Tyr-OCH3 (Methyl ester)  
GO (0.20 g) was dispersed in deionised water (100 mL) and sonicated with ultrasonic oscillation 
for 3 hours.  L-tyrosine methyl ester (2.0 g, 12 mmol), DMAP (2.93 g, 24.0 mmol), triethylamine 
(3.67 g, 36.0 mmol) and EDC.HCl (4.64 g, 24.0 mmol) were added. The mixture was stirred at 
75 °C for 24 hours. The reaction was allowed to cool to room temperature and the solids collected 
by filtration. The solid was washed with brine (100 mL x 3) and the filtrate centrifuged for 45 
minutes (at 4000 rpm). The precipitates produced were washed again with water and ethanol and 
dried at 60 °C. The product (0.34 g) was obtained as a black solid. 
Graphene Oxide - Tyr (Mono-Deprotection)  
GO (0.20 g) was dispersed in 100mL of deionised water and was sonicated with ultrasonic 
oscillation for 4 hours. The mixture was mixed with 20 mL of KOH (2 M) and stirred at 75 °C for 
24 hours. The reaction mixture was allowed to cool to room temperature. 20 mL of sulfuric acid 
(2 M) was added and the mixture sonicated with ultrasonic oscillation for 4 hours. The solid was 
washed with brine solution (100 mL x 4), collected by filtration and dried in a vacuum oven at 
60 °C overnight.  The product (0.33g) was obtained as a black powder. 
Graphene Oxide - Tyr (Oligo)  
GO (0.20 g,) was dispersed in deionised water (100 mL) and sonicated with ultrasonic oscillation 
for 4 hours.  Excess L-tyrosine (10 g) and DMAP (2.93 g, 24.0 mmol), triethylamine (3.67 g, 36.0 
mmol) and EDC.HCl (4.64 g, 24.0 mmol) were added. The reaction mixture was stirred at 75 °C 
for 24 hours. The reaction mixture was allowed to cool at room temperature and the solids collected 
and washed with brine (100 mL x 4). The filtrate was centrifuged for 45 minutes (4000 rpm) and 
the supernatant produced was decanted away. The solids were washed with water and ethanol. The 
product was dried at in a vacuum oven 60 °C overnight to yield the product (0.31 g) as a black 
solid. 
 
Kinetic Studies  
Assay of GO-Chymotrypsin Activity 
The enzyme activity was measured at a BTNA (substrate) concentrations of 2.0 たM, 4.0 たM, 6.0 
たM and 8.0 たM and concentrations of GO/functionalised GO of 0.0 たM, 0.06 たM, 0.12 たM, 0.24 
たM and 0.48 たM. All experiments were performed at an enzyme concentration of 0.4 たM. Initial 
velocity for each GO/substrate combination was obtained by linear fittings of 4-nitroaniline 
production over time using Graphpad prism 7.0.  All measurements were recorded at least three 
times. The data obtained  was plotted and anylysed using the mixed mode inhibition model  (within 
Graphpad) and transformed  into Lineweaver-burk plots. 
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SUPPORTING INFORMATION 
Characterization data of the functionalized systems (including elemental data, SEM-EDX, XRD,  
IR and Raman, XPS and CD.  Plots used to obtain the kinetic data for the GO and GO-Tyr (oligo). 
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